Aachen, Germany

Simone Dorfmüller

This inventor holds 1 USPTO granted patent. Top assignee: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.. Active years: 2009.


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Simone Dorfmüller: Innovator in Plant Disease Resistance

Introduction

Simone Dorfmüller is a prominent inventor based in Aachen, Germany. She has made significant contributions to the field of biotechnology, particularly in developing methods for enhancing plant disease resistance. Her innovative work focuses on utilizing antibodies and recombinant technologies to combat fungal infections in plants.

Latest Patents

Dorfmüller holds a patent for "Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi." This patent outlines a method for producing fungus-resistant transgenic plants, plant cells, or plant tissue. The process involves introducing specific antibodies or vectors into the genome of the plants, thereby enhancing their resistance to fungal diseases.

Career Highlights

Simone Dorfmüller is affiliated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a leading research organization in applied sciences. Her work has been instrumental in advancing agricultural biotechnology and improving crop resilience.

Collaborations

Dorfmüller has collaborated with notable colleagues, including Yu-Cai Liao and Dieter Peschen. These partnerships have fostered innovation and contributed to the success of her research initiatives.

Conclusion

Simone Dorfmüller's contributions to plant disease resistance through her innovative patent and collaborative efforts highlight her role as a key figure in biotechnology. Her work continues to pave the way for advancements in agricultural resilience and sustainability.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…